MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Constipation"

  • 2019 International Congress

    Characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease

    T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, H. Nakajima, R. Sakakibara, S. Kuwabara, K. Hirata, M. Murai (Chiba, Japan)

    Objective: To evaluate the characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease (PD). Background: Lower gastrointestinal tract dysfunction is common in patients…
  • 2019 International Congress

    Characterization of the gastrointestinal dysfunction in the 6-hydroxydopamine rat model of Parkinson’s disease

    X. Chai, S. Diwakarla, R. Pustovit, R. Mcquade, M. Di Natale, C. Ermine, C. Parish, D. Finkelstein, J. Furness (Melbourne, Australia)

    Objective: To characterize the gastrointestinal (GI) phenotype in the 6-hydroxydopamine (6OHDA) rat model of Parkinson’s disease (PD). Background: GI dysfunction, such as prolonged GI transit…
  • 2019 International Congress

    A Prospective Study of the Effects of Deep Brain Stimulation on Constipation and Olfaction in Parkinson Disease

    S. Kola, A. Bharucha, D. Prichard, K. Feuerhak, A. Hassan (Rochester, MN, USA)

    Objective: To investigate the effects of subthalamic nucleus deep brain stimulation (STN-DBS) on constipation and olfaction in patients with Parkinson disease (PD). Background: STN-DBS is…
  • 2019 International Congress

    Gastrointestinal microbiome in Parkinson’s disease in a Bavarian cohort

    F. Marxreiter, A. Cosma-Grigorov, H. Gassner, H. Meixner, Z. Kohl, M. Neurath, S. Wirtz, J. Winkler (Erlangen, Germany)

    Objective: Our goal was to evaluate, whether gut microbiota are altered in a Southern German PD cohort. In addition, we assessed changes in the microbiome…
  • 2019 International Congress

    Path to Prevention (P2P) – Developing a Prodromal PD Progression Biomarker Program

    K. Marek, A. Siderowf, C. Coffey, T. Foroud, V. Arnedo, E. Flagg, S. Chowdhury, K. Kieburtz, L. Chahine, J. Seibyl (New Haven, CT, USA)

    Objective: The overall objective of the Path to Prevention (P2P) initiative is to identify clinical, imaging, and biologic markers of progression during the prodromal phase…
  • 2019 International Congress

    The Dutch Parkinson and Microbiome Study (DUPARM): Gut Microbiome Composition of Treatment-Naïve De Novo Parkinson’s Disease Patients

    J. Boertien, S. Vander Zee, T. van Laar (Groningen, Netherlands)

    Objective: To establish the gut microbiome composition of de novo Parkinson’s disease (PD) patients with no history of dopaminergic medication use. Background: PD is often…
  • 2019 International Congress

    Comprehensive clinico-pathophysiological assessment of constipation in Parkinson’s disease

    E. de Pablo-Fernandez, V. Passananti, N. Zárate-López, A. Emmanuel, T. Warner (London, United Kingdom)

    Objective: To perform a comprehensive assessment of constipation in Parkinson’s disease (PD) using various complementary diagnostic techniques to elucidate its pathophysiology and improve its symptomatic…
  • 2019 International Congress

    The ultrasonographic assessment of vagus nerve atrophy comparison with autonomic dysfunction in Parkinson’s disease

    T. Hirato, S. Abe, H. Saiki (Kita-Ku, Osaka, Japan)

    Objective: To investigate the relationship between vagus nerve atrophy and clinical manifestation in Parkinson’s disease (PD). Background: PD is the progressive neurodegenerative disease and causes…
  • 2019 International Congress

    Evaluation of Constipation in Patients with Parkinson’s Disease and its Correction

    M. Salokhiddinov, D. Akramova (Tashkent, Uzbekistan)

    Objective: To evaluate the possible causes of constipation, and to find clear methods to correct the disorder. Background: Constipation is a common problem in Parkinson's…
  • 2019 International Congress

    Intestinal nerve damage and gut dysfunction in mouse models of Parkinson’s Disease

    R. Mcquade, R. Constable, E. Lei, M. Di Natale, J. Berger, J. Kauhausen, C. Parish, D. Finkelstein, J. Furness, S. Diwakarla (Melbourne, Australia)

    Objective: This work aims to investigate gut dysfunction and enteric neuropathy in several mouse models of PD to provide insight into enteric nervous system (ENS)…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley